Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: VAUGHN who wrote (8488)	1/23/2002 1:00:26 PM
From: Tom Johnson	Respond to of 14101

Thanks Vaughn.About time! I took the liberty of posting it on SH.

To: VAUGHN who wrote (8488)	1/23/2002 2:45:54 PM
From: Cal Gary	Respond to of 14101

Thanks Vaughn Any Ottawa/Hull based DMXer able to attend? A number of Pharmas are sponsorers. Health Canada reps will be there too. I wonder if DMX couldn't free up some marketing types and send them to this conference?? "Join us in Ottawa Canadians for Best Medicines 2nd National Summit on Reform of Canada's Drug Review System January 25-27, 2002 Chateau Cartier, Aylmer, Quebec Sponsored by: RX&D Canada's Research-Based Pharmaceutical Companies GlaxoSmithKline Inc. Aventis Pharma Canada Bristol-Myers Squibb Pharmaceutical Group Lorus Therapeutics Inc. Pfizer Canada Purdue Pharma Sanofi-Synthelabo Canada Inc. Partner Organizations: Arthritis Consumer Experts (ACE) Canadian Lung Association Canadian Diabetes Association Colorectal Cancer Association of Canada The Arthritis Society (TAS) Cancer Advocacy Coalition of Canada Heart and Stroke Foundation of Canada " piscesonline.ca Check out the Summit's Itinerary!!

To: VAUGHN who wrote (8488)	1/24/2002 10:49:42 AM
From: Cal Gary	Respond to of 14101

Further on this subject, DMX would make a great case study for a conference workshop. A company with a clinically proven product, efficacy and safety, targeting OA patients. OA is chronic, no cures available, some on drugs for years. Documented cases of hositalizations and even deaths due to competitor's NSAID products. Pennsaid meandering in the HC queue for years. Completed Phase I, II, III, IV, III, then way past 300th day for a reply. Oh, did I mention DMX would make a great case study at the conference workshop. [EDIT] The DMX balancing act. I feel DMX's low key, don't rock the boat stance with HC did not help their cause. Having said that, I do understand unnecessary media hype would hurt their cause with HC (and FDA). Just 'filler' thoughts.